Literature DB >> 9294124

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Y Abu-Amer1, F P Ross, J Edwards, S L Teitelbaum.   

Abstract

Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF. Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS. An anti-TNF antibody blocks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro. Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo. In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor. Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294124      PMCID: PMC508337          DOI: 10.1172/JCI119679

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Bacterial endotoxins.

Authors:  E T Rietschel; H Brade
Journal:  Sci Am       Date:  1992-08       Impact factor: 2.142

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The cellular mechanism of ossicular erosion in chronic suppurative otitis media.

Authors:  F J Lannigan; P O'Higgins; P Mcphie
Journal:  J Laryngol Otol       Date:  1993-01       Impact factor: 1.469

4.  The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; T Sasaki; A Yamaguchi; H Kodama; T J Martin; T Suda
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

5.  Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D.

Authors:  Y Abu-Amer; Z Bar-Shavit
Journal:  J Cell Biochem       Date:  1994-08       Impact factor: 4.429

6.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

Authors:  L A Tartaglia; D V Goeddel; C Reynolds; I S Figari; R F Weber; B M Fendly; M A Palladino
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

8.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Osteoclasts express high levels of pp60c-src in association with intracellular membranes.

Authors:  W C Horne; L Neff; D Chatterjee; A Lomri; J B Levy; R Baron
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  86 in total

1.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis.

Authors:  J Lam; Y Abu-Amer; C A Nelson; D H Fremont; F P Ross; S L Teitelbaum
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 3.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

4.  Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.

Authors:  Tao Ma; Kavitha Sadashivaiah; Nandakumar Madayiputhiya; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

Review 5.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

6.  Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection.

Authors:  C P Chen; M Hertzberg; Y Jiang; D T Graves
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.

Authors:  Bethany L V Cuetara; Tania N Crotti; Anthony J O'Donoghue; Kevin P McHugh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

8.  Osteoclasts: what do they do and how do they do it?

Authors:  Steven L Teitelbaum
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

9.  Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase.

Authors:  Sandip Bhattacharyya; Diane E Brown; Judson A Brewer; Sherri K Vogt; Louis J Muglia
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

10.  Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Authors:  Robert Nason; Jae Y Jung; Richard A Chole
Journal:  J Assoc Res Otolaryngol       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.